发明名称 Crystallization method for purification of calcipotriene
摘要 Provided is a crystallization method for reducing the level of impurities in calcipotriene in which a solution of a starting calcipotriene in a first process solvent, for example THF, is combined with second process solvent, for example methyl formate, and, after cooling, calcipotriene is isolated. The method can include a slurry step for reducing the level of residual first process solvent.
申请公布号 US2008161587(A1) 申请公布日期 2008.07.03
申请号 US20080075066 申请日期 2008.03.07
申请人 TEVA PHARMACEUTICALS USA, INC. 发明人 SCHWARTZ ANCHEL;MAIMON ASHER
分类号 C07C401/00 主分类号 C07C401/00
代理机构 代理人
主权项
地址